Platform Analysis

Compare Platforms

Side-by-side analysis of leading human simulation technologies

Organ-on-Chip

Organ-on-Chip Platform Comparison

Leading MPS platforms compared by key features

Feature Emulate CN Bio TissUse Mimetas
Platform Name Human Emulation System PhysioMimix HUMIMIC OrganoPlate
FDA ISTAND ✓ Qualified In progress No No
Multi-Organ Limited ✓ Yes ✓ Yes Limited
Throughput Medium (12 chips) Medium (12 plates) Low-Medium High (96/384)
Key Organs Liver, Lung, Gut, Brain Liver, Gut, Multi-organ Multi-organ systems Kidney, BBB, Tumor
Flow Type Pneumatic stretch Peristaltic pump On-chip pumps Gravity-driven
Founded 2014 2009 2010 2013
Funding $225M+ $50M+ Acquired $60M+
AI Drug Discovery

AI Drug Discovery Platform Comparison

Leading AI platforms compared by approach and pipeline

Feature Recursion Insilico Exscientia Schrödinger
Primary Approach Cell imaging + ML Generative AI AI drug design Physics-based
Clinical Assets Phase 2 (CCM) Phase 2 (IPF) Phase 1-2 Multiple partnerships
Status Public (RXRX) Private (Series D) Public (EXAI) Public (SDGR)
Data Scale 30PB+ images Proprietary datasets Pharma partnerships Physics calculations
Key Partnerships Nvidia, Roche Sanofi, multiple BMS, Sanofi All top 20 pharma
Funding/Revenue $1.5B+ $400M+ $700M+ raised $700M+ revenue
Organoids

Organoid Platform Comparison

Leading organoid platforms by cell source and applications

Feature HUB Organoids Crown Bioscience InSphero
Cell Source Adult stem cells Patient-derived tumors Primary cells
Primary Focus Research biobank Oncology CRO ADME-Tox
Platform Organoid biobank HuTumorX 3D InSight/Akura
Status Acquired by Merck JSR Owned Private (Series B)
Headquarters Utrecht, Netherlands Global (Suzhou HQ) Zurich, Switzerland
Selection Guide

Platform Selection Guide

For DILI/Hepatotoxicity

Emulate - FDA ISTAND qualified Liver-Chip with 87% sensitivity, 100% specificity.

For Multi-Organ ADME

CN Bio or TissUse - Connected organ systems for systemic drug response.

For High-Throughput Screening

Mimetas OrganoPlate - 96/384-well format with gravity-driven flow.

For Oncology PDX

Crown Bioscience - HuTumorX with 2,500+ patient-derived tumor models.

For AI-Driven Discovery

Recursion for phenotypic, Insilico for generative, Schrödinger for physics-based.

For 3D Liver Toxicity

InSphero - 3D InSight liver microtissues for DILI and metabolic studies.

Explore More Analysis

Dive deeper into platform capabilities and market positioning

Technology Matrix Partnership Network All Companies